Havas Health Network Leadership Visited Shanghai General Hospital

On the morning of August 29, Mr. Charles Houdoux, Chief Client Officer and CEO of Asia-Pacific and South America for Havas Health Network, along with Mr. Wang Tao, Managing Director of Havas Health Network China, and Mr. Ren Zhongyang, Deputy General Manager of Havas Health Network China, visited Shanghai General Hospital. The International Cooperation and Exchange Department warmly welcomed Mr. Houdoux and his team, giving them a tour on the Hospital's History Museum, the Smart Hospital Command Center, the Ophthalmology Clinical Medical Center and the Public Laboratory, and the International Medical Care Center.

As a prominent member of the global Havas Group, Havas Health & You is at the forefront of healthcare and wellness communications. The network provides a broad array of services including healthcare advertising, medical communications, public relations, digital marketing, and market access. Havas boasts a global network spanning 60 countries, supported by a robust team of over 6,000 medical experts, 225 medical professionals, and 1,200 digital and CX specialists. It features specialized agencies like Havas Health, Havas Lynx, and Havas Life, each focusing on different aspects of health communications. Known for its human-centric and data-driven approach, Havas Health & You is committed to creating meaningful connections through innovative solutions.

During the visit, Mr. Houdoux, a distinguished expert in healthcare from France, expressed admiration for the impressive progress made by Chinese medical institutions. He specifically commended Shanghai General Hospital for its advancements in clinical treatment, hospital environment development, and intelligent applications, noting that these achievements are competitive on a global scale.

Mr. Wang Tao conveyed his appreciation for the opportunity to visit Shanghai General Hospital, highlighting the significance of the visit to both Havas Health Network and the hospital. He expressed a strong desire for future collaboration, underscoring the mutual benefits that such a partnership could bring. Mr. Wang emphasized that through joint efforts, there is great potential to contribute meaningfully to the ambitious "Healthy China 2030" initiative, aiming to advance public health and wellness on a national scale.

In conclusion, the visit by Havas Health Network's leadership to Shanghai General Hospital highlights a promising beginning for future collaboration. Both parties are optimistic about the potential synergies and shared goals, particularly in advancing the "Healthy China 2030" initiative. This partnership is poised to drive significant contributions to healthcare innovation and public health improvements, setting a positive trajectory for both institutions in their commitment to excellence and community well-being.